Medical Records Based Real-World Study of Cetuximab in Combination with FOLFIRI Regimen as First-Line Chemotherapy and Subsequent Cetuximab-based Maintenance Therapy for the Maintenance Treatment of Patients with RAS and BRAF Wild-Type Unresectable Metastatic Colorectal Cancer
Ontology highlight
ABSTRACT: Interventions: Maintenance group:Nil
Primary outcome(s): Progression Free Survival;Adverse Events;Failure-free survival
Study Design: Sequential
DISEASE(S): Colorectal Cancer
PROVIDER: 2701129 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA